Hyperoxaluria

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
2 Unique IMPs
2 Commercial trials
Drug classes (ATC)
A Gastroenterology (ATC A) 1
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
siRNA 2 substances
Phase III: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

2 trials
  • Alnylam Pharmaceuticals Inc. Commercial
    LUMASIRAN
    2023-503382-29-00 4 countries 2020 n=7 Orphan
    Ended
  • Dicerna Pharmaceuticals Inc. Commercial
    NEDOSIRAN
    2024-512260-54-00 6 countries 2019 n=29 Orphan
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Alnylam Pharmaceuticals Inc. Commercial 1 Phase III 0
Dicerna Pharmaceuticals Inc. Commercial 1 Phase III 0
New trials by year
2019
1
2020
1
← All indication landscapes